Nabla, a Boston, MA-based provider of an ambient AI assistant for practitioners, raised $24M in Series B funding.
The round, which brought the total amount to $43M, was led by Cathay Innovation with participation from Zebox Ventures.
The company intends to use the funds to expand capabilities and adoption of Nabla Copilot.
Led by CEO Alex Lebrun, Nabla is the developer of Nabla Copilot, an ambient AI that generates clinical notes in seconds from any encounter across all specialties, reducing practitioners’ stress and improving patient care. Nabla Copilot’s capabilities also include AI-enabled medical coding identification, and smooth EHR integrations. Available on mobile, desktop, and API, Nabla continually improves its user experience by applying feedback from its engaged clinician community. The company does not store data, complying with the highest confidentiality and privacy regulations.
Launched in March 2023, the copilot has experienced rapid growth with +20,000 providers who have already adopted the solution.
Founded in 2018, Nabla has proprietary Large Language Models (LLM) and Speech-to-Text (STT) technologies built by former Facebook AI Research engineers. Advisors include AI and medical experts, including the godfather of AI, Yann LeCun; Dr. Megan Mahoney, Professor and Chair at UCSF Department of Family and Community Medicine; Dr. Haipeng (Mark) Zhang, Associate Program Director of the Clinical Informatics and Innovation Fellowship at Brigham and Women’s Hospital; and Dr. Andrew Lundquist, Chief Medical Officer of the Mankato Clinic.
